NCT04805021Befejeződött
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. szept. 24.
Rövid összefoglaló (regiszter, angolul)
Acquired hemophilia A is a rare condition of hemostasis secondary to the development of antibodies against factor VIII. This is a potentially serious pathology that can be life-threatening due to the major risk of bleeding caused by the sometimes drastic decrease in the level of circulating factor VIII. This pathology occurs overwhelmingly in elderly subjects or, more rarely, in young women, during the postpartum period. It appears idiopathic in 50% of cases and associated, for the other cases, with underlying pathologies such as autoimmune pathologies (rheumatoid arthritis and bullous pemphigoid in particular) and neoplasias, or with a particular circumstance represented by the post -partum. The association between this autoimmune pathology and its association with pathologies of the same type or with circumstances involving the immune system, suggests that common mechanisms could favor its emergence. This study therefore proposes to study lymphocyte populations and subpopulations as well as Myeloid-Derived Suppressor Cells and the cytokine profile, which are abnormal in a large part of autoimmune pathologies.
- Állapot (regiszter)
- Befejeződött
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 36 (tényleges)
- Első benyújtás
- 2021. márc. 16.
- Kezdés
- 2021. nov. 30.
- Elsődleges befejezés
- 2024. márc. 25.
- Fő szponzor
- Nantes University Hospital
- Betegségek
- Hemofília
- NCT-szám
- NCT04805021
Mit vállalsz
- Vizsgálat típusa: Megfigyeléses
- Bevont résztvevők: 36
- 2021. nov. 30. és az elsődleges befejezés (2024. márc. 25.) között
- 2 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Treatment with corticosteroids in the 7 days preceding inclusion or any other immunomodulatory or immunosuppressive treatment in the 4 weeks preceding inclusion.
Egyéb
- For the 4 groups:
- Minor patient, under guardianship or curatorship.
- Pregnant and lactating women.
- Blood transfusion less than 7 days old.
Kiket keres a vizsgálat
- Patient population with acquired hemophilia A:
- Adult patients with a diagnosis of acquired hemophilia A and with a social security system. Obtaining oral non-opposition from the patient to participate in the study following the submission of an information note relating to the project.
- Obtaining signed and written informed consent for biocollection consent.
- Population of Patients with constitutional hemophilia A:
- Adult patients over 50 years of age with severe or moderate constitutional hemophilia A, with no history of autoimmune disease, and with a social security system.
- Obtaining oral non-opposition from the patient to participate in the study following the submission of an information note relating to the project.
- Obtaining signed and written informed consent for biocollection consent.
- Population of control subjects:
- Adult patients, over the age of 60, without a coagulation abnormality, with no history of autoimmune disease, and with a social security system.
- Obtaining oral non-opposition from the patient to participate in the study following the submission of an information note relating to the project.
- Obtaining signed and written informed consent for biocollection consent.
- Patient population with inflammatory pathology:
- Adult patients over the age of 50 with an inflammatory pathology likely to be associated with acquired hemophilia A, and with a social security system.
- Obtaining oral non-opposition from the patient to participate in the study following the submission of an information note relating to the project.
- Obtaining signed and written informed consent for biocollection consent.
Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket is fogad
Helyszínek (2)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| CHU de Nantes | Nantes | Franciaország | Ismeretlen állapot |
| CH de Saint Nazaire | Saint-Nazaire | Franciaország | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.